do glp 1 agonists have cardiovascular benefit benefits of glucagon-like peptide-1 receptor GLP-1 receptor agonists for cardiovascular

In our practice (SN), we routinely use gastric ultrasound (GUS) to guide clinical decision-making, supported by a dedicated team of credentialed POCUS experts available in the operating room

Diabetes Care 37, 27232730

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

NEW - Blue Shield will launch three PPO Savings Plans offering expanded weight loss drug coverage in 2027: Full PPO Savings Embedded Deductible 3400 100% with Enhanced+ Rx Full PPO Savings Two-Tier Embedded Deductible 1700/3400/3400 90/60 with Enhanced+ Rx NOTE: Weight loss drugs under these plans are covered with prior authorization for BMI 30 or 27 with certain weight-related conditions, lowering the requirement from the previous BMI of 40

At Conceive NJ, those discussions are handled through shared decision-making with the patient and the broader care team